Navigation Links
Kuros Announces Allowance of European Patent for Synthetic Biomaterials
Date:6/19/2011

ZURICH, June 20, 2011 /PRNewswire/ --


Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today the allowance of European Patent Application 00910049 by the European Patent Office. This now allowed patent application is a key component of a broad portfolio of applications and patents designed to protect Kuros’ synthetic biomaterial (matrix) technologies and its product candidates which utilise this technology. This novel synthetic matrix platform is a key source of innovative products which will be important to Kuros’ future successful development

Kuros is developing a portfolio of biomaterial, and bioactive-biomaterial combination, products. The company’s product candidates are based on two different matrix technology platforms; synthetic or fibrin matrices. Kuros’ most advanced product candidate based on its synthetic technology is Kuros’ dural sealant product candidate (KUR-023) which is currently undergoing clinical evaluation in Europe. Kuros intends that this clinical study will enable CE marking in Europe.

Kuros’ most advanced products are based on a fibrin matrix and include KUR-111 and KUR-113 which have achieved positive results in Phase II trials for tibial plateau fractures and tibial shaft fractures respectively.

Mr. Didier Cowling, Chief Executive Officer at Kuros says: "Obtaining the notice of allowance for this European patent application further builds on Kuros’ proprietary position around its key synthetic matrix technology platform.  This platform is the basis of
'/>"/>

SOURCE Kuros Biosurgery AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmacyclics Announces Results of Registered Direct Offering
2. K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
3. SCOLR Pharma, Inc. Announces Initial Closing of Private Placement
4. Chiltern Announces Additional Investment in Endpoint
5. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
6. Dendreon Announces Webcast Presentation at NASDAQ OMX 26th Investor Program
7. Access Legal Announces Appointment of Nicholas Tubb to Medical Negligence Team
8. Vermillion Announces Joining Russell Microcap® Index
9. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
10. Merriman Capital Announces Sponsorship of Circadian Technologies on OTCQX
11. INVO Bioscience Announces Planned Submission To ANVISA For Brazilian Approval Following Completion of Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... of last week RENU 28, the world's first and only ... purchase in Australia and New Zealand, and the response has ... if you think about the definition of aging, it's really ... your body. If you think about the definition of anti-aging, ... RENU 28 does is it works with these tiny little ...
(Date:8/20/2014)... lessons often have it that American Indians largely were ... pox, influenza and tuberculosis brought to the New World ... about 20 million people lived in the Americas shortly ... were killed by European diseases., But new research led ... and Johannes Krause of the University of Tubingen in ...
(Date:8/20/2014)... 20, 2014 High performance computing ... the most complete climate and Earth system model ... change issues. , Eight national laboratories, including ... National Center for Atmospheric Research, four academic institutions ... Other participating national laboratories include Argonne, Brookhaven, Lawrence ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... is being held on October 29-30 in San Francisco, ... industry, academic and government researchers and clinicians focused on ... space. , In the twelve years since the ... therapies have been introduced with pharmacogenetic information in the ...
Breaking Biology Technology:RENU 28 Skin Care Now Available in Australia and New Zealand 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 36th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2
... FRANCISCO , Jan. 13 Today, endpoint ( ... users to design and deploy clinical trial IRT systems in ... Leveraging a background of more than 12 years designing Integrated ... designed PULSE to balance speed of deployment with flawless quality. ...
... , BIRMINGHAM, Ala. , ... BCRX ) today announced that its partner, Shionogi & Co., ... peramivir to treat patients with influenza in Japan . ... RAPIACTA in Japan , pending the product,s National Health ...
... , , , , ... the Brazilian Sugarcane,Industry Association (UNICA), the federal government,s decision to ... must be limited to the,established 90-day period. , ... understandable,but the move must be limited to the 90-day period ...
Cached Biology Technology:endpoint Introduces First Fully Configurable IRT System 2BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan 2BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan 3BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan 4Ethanol Blend Reduction in Brazil 'Makes Sense' Provided 90-Day Deadline is Respected, Says Brazilian Sugarcane Industry Association 2Ethanol Blend Reduction in Brazil 'Makes Sense' Provided 90-Day Deadline is Respected, Says Brazilian Sugarcane Industry Association 3
(Date:8/21/2014)... has successfully replicated one of the crucial steps in ... sunlight which could manufacture hydrogen as a fuel. , ... an exciting prospect to use them to create hydrogen, ... Hingorani, from the ARC Centre of Excellence for Translational ... Hydrogen offers potential as a zero-carbon replacement for petroleum ...
(Date:8/21/2014)... involves the pancreas digesting itself resulting in severe abdominal ... UK around 20,000 patients are diagnosed with the disease ... and treatment is restricted to intravenous fluid and nutritional ... of Life Sciences, who led the research, said "The ... gall stones and excessive alcohol intake combined with a ...
(Date:8/20/2014)... study of 158 pregnant teenagers in Rochester, NY, nearly ... consumption of ice, cornstarch, vacuum dust, baby powder and ... study. , Moreover, such teens had significantly lower iron ... nonfood substances. , Pregnant teens, regardless of pica, are ... to iron deficiency and anemia. Low iron in pregnant ...
Breaking Biology News(10 mins):Water and sunlight the formula for sustainable fuel 2Insulin offers new hope for the treatment of acute pancreatitis 2Pica in pregnant teens linked to low iron 2
... studying fuels from biomass for years. Now, with growing ... biofuels are fast becoming part of a fuel revolution ... Ethanol blends are already available at some gas stations. ... on the volume of ethanol produced. Sources of biomass ...
... Katrina on soil quality and agriculture? How can soil help ... biofuels help make America energy independent? These topics and others ... Meetings of the American Society of Agronomy (ASA), Crop Science ... (SSSA) Nov. 4-8, 2007 at the Ernest N. Morial Convention ...
... in German . , Fossil remains of ... about their cognitive skills or give us details of ... team at the Max Planck Institute for Evolutionary Anthropology ... they have made some new and astonishing discoveries. Just ...
Cached Biology News:The race for biofuels driving alternative sources of biomass 2Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings 2Red hair and freckles... 2
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Request Info...
... Well Plate Sterile with ... range of 384-well plates ... screening and research. These ... and are suitable for ...
HLA-DRbeta (DA2)...
Biology Products: